Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Share and Forecast 2034
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Type (Emphysema and Chronic Bronchitis), By Drug Class (Mucokinetics, Corticosteroids, Combination Therapy, Phosphodiesterase Type Inhibitor, Bronchodilators, and Others), By Distribution Channel (Online Pharmacies, Retails Pharmacies, and Hospital Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 218 Report Code: ZMR-7967
Published Date: Nov-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 20.01 Billion | USD 33.03 Billion | 5.14% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, (2023 - 2030) (USD Billion)
- 2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market : snapshot
- Chapter 3. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Industry Analysis
- 3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing smoking addiction among the general population to drive market growth
- 3.3 Market Restraints
- 3.3.1. Absence of permanent cure for COPD to restrict market growth
- 3.4 Market Opportunities
- 3.4.1. Research & development (R&D) in terms of effective medical treatment may deliver high-growth opportunities
- 3.5 Market Challenges
- 3.5.1. High cost of treatment and ensuring patient adherence may challenge market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Type
- 3.7.2 Market attractiveness analysis By Drug Class
- 3.7.3 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Type Analysis
- 5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Type
- 5.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share, By Type, 2022 and 2030
- 5.2 Emphysema
- 5.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Emphysema, 2023 - 2030 (USD Billion)
- 5.3 Chronic Bronchitis
- 5.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Chronic Bronchitis, 2023 - 2030 (USD Billion)
- 5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Type
- Chapter 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Drug Class Analysis
- 6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Drug Class
- 6.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share, By Drug Class, 2022 and 2030
- 6.2 Mucokinetics
- 6.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Mucokinetics, 2023 - 2030 (USD Billion)
- 6.3 Corticosteroids
- 6.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Corticosteroids, 2023 - 2030 (USD Billion)
- 6.4 Combination Therapy
- 6.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Combination Therapy, 2023 - 2030 (USD Billion)
- 6.5 Phosphodiesterase Type Inhibitor
- 6.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Phosphodiesterase Type Inhibitor, 2023 - 2030 (USD Billion)
- 6.6 Bronchodilators
- 6.6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Bronchodilators, 2023 - 2030 (USD Billion)
- 6.7 Others
- 6.7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Others, 2023 - 2030 (USD Billion)
- 6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Drug Class
- Chapter 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Distribution Channel Analysis
- 7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Distribution Channel
- 7.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share, By Distribution Channel, 2022 and 2030
- 7.2 Online Pharmacies
- 7.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 7.3 Retails Pharmacies
- 7.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Retails Pharmacies, 2023 - 2030 (USD Billion)
- 7.4 Hospital Pharmacies
- 7.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Hospital Pharmacies, 2023 - 2030 (USD Billion)
- 7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market overview: By Distribution Channel
- Chapter 8. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Regional Analysis
- 8.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Regional Overview
- 8.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share, by Region, 2022 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.3.1.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Country, 2023 - 2030 (USD Billion)
- 8.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030
- 8.4.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030 (USD Billion)
- 8.5 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030
- 8.5.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030 (USD Billion)
- 8.6 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030
- 8.6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Country, 2023 - 2030 (USD Billion)
- 8.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030
- 8.4.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030 (USD Billion)
- 8.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030
- 8.5.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030 (USD Billion)
- 8.6 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.5.3.1 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Country, 2023 - 2030 (USD Billion)
- 8.5.3 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030
- 8.4.1 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030 (USD Billion)
- 8.5 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030
- 8.5.1 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030 (USD Billion)
- 8.6 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.6.4.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Country, 2023 - 2030 (USD Billion)
- 8.6.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030
- 8.4.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030 (USD Billion)
- 8.5 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030
- 8.5.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030 (USD Billion)
- 8.6 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Country, 2023 - 2030 (USD Billion)
- 8.7.5 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 8.4 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030
- 8.4.1 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Type, 2023 - 2030 (USD Billion)
- 8.5 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030
- 8.5.1 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class, 2023 - 2030 (USD Billion)
- 8.6 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030
- 8.6.1 The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Boehringer Ingelheim
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 GlaxoSmithKline
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Sunovion Pharmaceuticals
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 AstraZeneca
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Circassia Pharmaceuticals
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Novartis
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Roche
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Teva Pharmaceutical Industries
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Theravance Biopharma
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Pfizer
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Mylan N.V.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Pearl Therapeutics
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Sanofi
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Merck & Co.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Chiesi Farmaceutici S.p.A.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 and others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Boehringer Ingelheim
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market attractiveness, By Type
- 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market attractiveness, By Drug Class
- 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market attractiveness, By Distribution Channel
- 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share by Type, 2023 and 2030 (USD Billion)
- 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Emphysema, 2023 - 2030 (USD Billion)
- 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Chronic Bronchitis, 2023 - 2030 (USD Billion)
- 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share by Drug Class, 2023 and 2030 (USD Billion)
- 12. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Mucokinetics, 2023 - 2030 (USD Billion)
- 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Corticosteroids, 2023 - 2030 (USD Billion)
- 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Combination Therapy, 2023 - 2030 (USD Billion)
- 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Phosphodiesterase Type Inhibitor, 2023 - 2030 (USD Billion)
- 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Bronchodilators, 2023 - 2030 (USD Billion)
- 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Others, 2023 - 2030 (USD Billion)
- 18. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share by Distribution Channel, 2023 and 2030 (USD Billion)
- 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 20. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Retails Pharmacies, 2023 - 2030 (USD Billion)
- 21. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Hospital Pharmacies, 2023 - 2030 (USD Billion)
- 22. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market share, by Region, 2023 and 2030
- 23. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 24. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 25. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 26. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
- 27. The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Snapshot
- 2. Drivers of the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: impact analysis
- 3. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 4. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 5. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 6. U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 7. U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 8. U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 9. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 10. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 11. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 12. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 13. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 14. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 15. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 16. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 17. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 18. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 19. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 20. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 21. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 22. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 23. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 24. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 25. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 26. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 27. Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 28. Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 29. Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 30. Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 31. Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 32. Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 33. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 34. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 35. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 36. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 37. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 38. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 39. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 40. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 41. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 42. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 43. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 44. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 45. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 46. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 47. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 48. South-East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 49. South-East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 50. South-East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 51. Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 52. Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 53. Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 54. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 55. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 56. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 57. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 58. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 59. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 60. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 61. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 62. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 63. Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 64. Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 65. Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 66. The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 67. The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 68. The Middle-East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 69. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 70. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 71. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 72. South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 73. South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 74. South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 75. Rest of Middle-East Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Type, 2023 - 2030 (USD Billion)
- 76. Rest of Middle-East Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 77. Rest of Middle-East Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Chronic obstructive pulmonary disease (COPD) is a lung-related chronic medical condition. It results in restricted airflow in the lungs.
The global chronic obstructive pulmonary disease (COPD) treatment market is expected to grow owing to the increasing number of people across the globe being addicted to smoking regularly.
According to study, The global chronic obstructive pulmonary disease (COPD) treatment market size was worth around USD 20.01 billion in 2024 and is predicted to grow to around USD 33.03 billion by 2034 with a compound annual growth rate (CAGR) of roughly 5.14% between 2025 and 2034.
The CAGR value of chronic obstructive pulmonary disease (COPD) treatment market is expected to be around 5.14% during 2025-2034
The global chronic obstructive pulmonary disease (COPD) treatment market will be led by North America during the forecast period.
The global chronic obstructive pulmonary disease (COPD) treatment market is led by players like Boehringer Ingelheim, GlaxoSmithKline, Sunovion Pharmaceuticals, AstraZeneca, Circassia Pharmaceuticals, Novartis, Roche, Teva Pharmaceutical Industries, Theravance Biopharma, Pfizer, Mylan N.V., Pearl Therapeutics, Sanofi, Merck & Co., and Chiesi Farmaceutici S.p.A.
The report explores crucial aspects of the chronic obstructive pulmonary disease (COPD) treatment market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
List of Contents
TreatmentIndustry Perspective: Treatment OverviewKey Insights: Treatment Growth Drivers Treatment Restraints Treatment Opportunities Treatment Challenges Treatment Segmentation Treatment Report Scope Treatment Regional Analysis Treatment Competitive AnalysisThe global chronic obstructive pulmonary disease (COPD) treatment market is segmented as follows:By RegionHappyClients
